Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-122840
Filing Date
2024-11-07
Accepted
2024-11-07 08:31:40
Documents
74
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mbx-20240930.htm   iXBRL 10-Q 2598284
2 EX-31.1 mbx-ex31_1.htm EX-31.1 16032
3 EX-31.2 mbx-ex31_2.htm EX-31.2 16142
4 EX-32.1 mbx-ex32_1.htm EX-32.1 14783
  Complete submission text file 0000950170-24-122840.txt   8339827

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT mbx-20240930.xsd EX-101.SCH 1084212
77 EXTRACTED XBRL INSTANCE DOCUMENT mbx-20240930_htm.xml XML 1176029
Mailing Address 12406 HORESHAM STREET CARMEL IN 46032
Business Address 12406 HORESHAM STREET CARMEL IN 46032 3179893100
MBX Biosciences, Inc. (Filer) CIK: 0001776111 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42272 | Film No.: 241433359
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)